Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
6
×
novartis
6
×
boston blog main
boston top stories
fda
new york top stories
san francisco top stories
clinical trials
indiana blog main
indiana top stories
national
new york blog main
san francisco blog main
amgen
biogen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe top stories
genentech
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
europe blog main
gene therapy
ipo
roche
What
fda
6
×
drug
medicines
new
approval
bio
roundup
therapy
won
acquire
activity
address
agreed
amgen
approvals
approved
approves
atrophy
august
billion
biogen
biotech
blueprint
brings
busy
cancer
candidates
carries
cash
certain
cholesterol
clamped
class
company
compound
covid
daily
days
deal
decisions
Language
unset
Current search:
novartis
×
" national top stories "
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines